Loading clinical trials...

Indicated Prevention With At-Risk Gamblers | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00078273

Indicated Prevention With At-Risk Gamblers

The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related neg...

Lead sponsor: University of Washington•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Integrative Couple Treatment for Gambling/Substance Use Disorder

NCT05833503 · Gambling Disorder, Substance Use Disorders

RECRUITINGNA

The Effect of Theta-burst Stimulation on Serum BDNF

NCT05854706 · Gambling Disorder

RECRUITINGPhase 3

Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation

NCT03669315 · Gambling Disorder

Not Yet Recruiting

Work Organization and Gambling Addiction

NCT07455981 · Problem Gambling, Addiction Gambling

COMPLETED

Covid-19 and ONline GAmbling

NCT04714008 · Gambling, Covid19

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 11, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment225

Start dateJul 2003

Last updatedDec 11, 2013

Condition

Gambling Pathological Gambling Problem Gambling

Locations shown

University of Washington; Department of Psychiatry and Behavioral Sciences

Seattle, Washington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 11, 2013Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions